U.S. Airlines Stock News

Thinking about what to do with e.l.f. Beauty stock right now? You’re definitely not alone. With shares closing at $137.32, investors are weighing up whether the company’s next move is a breakout or another test of nerves. If you zoom out, the story gets even more interesting: the stock has soared 254.4% over the past three years, and an eye-popping 632.4% in the last five. That kind of momentum doesn't go unnoticed, and it certainly raises questions about growth potential, risk, and, of...

In September 2025, Verisk announced the launch of its Commercial GenAI Underwriting Assistant, a cloud-based generative AI solution designed to streamline and modernize commercial property underwriting for insurers by automating workflows, delivering real-time risk insights, and supporting expert judgment through a human-in-the-loop design. This launch addresses key industry pain points such as rising costs, workforce shortages, and demand for digital transformation, while integrating...

On September 15, 2025, Ultra Clean Holdings, Inc. amended its existing credit agreement, reducing the interest rate on its term loan facility by 0.5% per annum after reaching an agreement with Barclays Bank PLC and lenders. This debt refinancing move highlights the company’s efforts to decrease borrowing costs and improve financial flexibility, following a period of mixed profitability and recent insider buying activity. We will explore how Ultra Clean Holdings' reduced borrowing costs could...

Trying to decide what to do with Yext stock right now? You are definitely not alone. With its recent closing price at $8.83, Yext has caught the attention of investors curious about the next chapter for this digital business solutions firm. Over the past year, shares are up a striking 37.3%, and the year-to-date performance is even more impressive at 35.0%. Looking further back, the stock nearly doubled with a 97.5% increase over three years, but it remains down 42.7% over five years. This...

Post Holdings (POST) in Focus: Is the Market Too Cautious? If you have been eyeing Post Holdings (POST) lately, you are not alone. Shares have slid in recent months as the market reacts to slowing sales volumes, tighter free cash flow margins, and what some call lackluster returns on prior investments. It is enough to make any investor question if this is just temporary turbulence or a sign of deeper issues for the food giant. Looking at the bigger picture, the stock’s performance has...

In September 2025, Sally Beauty announced its partnership with DoorDash to launch the "Beauty on the Go" pop-up event in New York City, blending professional beauty expertise with on-demand delivery from September 25–27. This collaboration highlights DoorDash's push to address more consumer segments and convenience needs by expanding beyond its restaurant-focused origin. We'll examine how DoorDash's entry into beauty and home improvement delivery could influence its evolving investment...

Earlier this month, Krystal Biotech announced that the FDA approved a label update for VYJUVEK®, expanding its eligibility to include dystrophic epidermolysis bullosa patients from birth and allowing greater flexibility in wound care management based on real-world safety and efficacy data. This expansion meaningfully broadens VYJUVEK's treatable patient base in the US and may strengthen the company's competitive position in global genetic dermatology markets. To assess how this FDA approval...

Assurant (AIZ) is shaking things up with its latest move: announcing a strategic partnership with Evident to launch the commercial equipment rental industry's first end-to-end risk management solution. This collaboration stands out by combining automated insurance verification with Assurant-backed protection programs, directly addressing pain points for companies in sectors like construction and agriculture. For investors, this is not just a new product; it is a material development that...

If you are weighing your next move with Merck (MRK), there is a new wrinkle worth a close look. The company just scored U.S. FDA approval for Keytruda QLEX, a novel subcutaneous version of its blockbuster cancer medicine. Instead of the lengthy intravenous infusions most patients endure, the new injection can be given in as little as one minute, covering most of the same cancer types Keytruda already fights. This regulatory win is not just about convenience; it could reshape how Merck defends...

Stamus and SentinelOne recently announced the next phase of their partnership, integrating Stamus’ Clear NDR threat intelligence with SentinelOne’s AI-native Singularity Platform to provide unified, AI-powered network and endpoint security detection and response. This collaboration highlights the importance of comprehensive, high-quality data for powering AI cybersecurity solutions, helping address alert fatigue and ensuring security teams have full visibility across all attack...

SL Green Realty Corp., in partnership with PGIM, recently completed a US$1.4 billion refinancing of 11 Madison Avenue and executed two transactions at 1552-1560 Broadway in Times Square, including a discounted debt acquisition and finalized long-term ground leases. These developments reflect robust institutional demand for Manhattan Class A assets and signal enhanced portfolio quality and income potential for SL Green's prime properties. We'll explore how the completion of the 11 Madison...

Earlier in September 2025, Grand Canyon Education received an analyst upgrade to a Zacks Rank #1 (Strong Buy) following a consistent rise in earnings estimates by sell-side analysts. This upgrade reflects increasing analyst confidence in Grand Canyon Education’s operational discipline and suggests its management’s investment and cost control strategies are gaining recognition. We'll explore how this improved analyst outlook for future earnings could influence Grand Canyon Education’s...

Blackstone Mortgage Trust (NYSE:BXMT) just announced a substantial leadership shakeup, with Timothy S. Johnson taking the reins as CEO and F. Austin Peña stepping in as President. Both appointments are set for November 10. The news comes as Katharine A. Keenan exits to lead Blackstone Real Estate Income Trust, positioning two familiar figures at the helm to maintain continuity during this transition. With Johnson’s deep background in real estate debt strategies and Peña’s experience...

CoreCivic, the US-based operator of correctional facilities, is back in the spotlight after delivering a standout quarterly performance that topped expectations. The latest results not only exceeded forecasts but also set the company apart from industry peers, especially in a quarter when others in the sector faced disappointing guidance or weaker results. For investors wondering if there is something special unfolding here, the recent earnings beat is certainly a development to track. The...

If you’re wondering how to play Cleveland-Cliffs (CLF) right now, you’re not alone. Shares have dropped for a second straight day as investors digest news surrounding President Trump’s trip to the UK, where steel trade talks are front and center. The U.S. government’s fresh signal that tariffs on UK steel will stay in place, rather than being scrapped, could have lasting effects for American steelmakers like CLF, whose fortunes are often tied to trade policy moves like this one. This isn’t...

On September 16, 2025, Paylocity introduced an upgraded AI Assistant for its ONE platform, enabling users to instantly access answers, data, and workflows across HR and finance tasks through natural language queries on desktop and mobile devices. This enhancement illustrates Paylocity's focus on simplifying complex workforce processes while supporting HR teams and employees with personalized, intelligent automation. We'll now explore how Paylocity's upgraded AI Assistant could further...

Earlier this month, NovoCure announced that Japan's Ministry of Health, Labour and Welfare approved Optune Lua for use with PD-1/PD-L1 inhibitors in adult patients with unresectable advanced or recurrent non-small cell lung cancer who have progressed on or after platinum-based chemotherapy. This regulatory approval highlights the growing international acceptance and expanding clinical applications of Tumor Treating Fields therapy in major oncology markets. We'll explore how access to Japan's...

Earlier this week, Amer Sports raised its third-quarter 2025 revenue growth forecast to the high-20s percentage range, up from its previous estimate of around 20%, and projected operating margin to come in at or above the upper end of its prior guidance. This revised outlook was presented alongside new long-term financial targets, emphasizing strong momentum in the Arc’teryx and Salomon brands and the company’s accelerated focus on global retail expansion. We’ll now explore how Amer Sports’...

If you’re wondering whether Butterfly Network (BFLY) deserves a spot on your watchlist right now, you’re not alone. The company has just been named to TIME’s first-ever list of the World’s Top HealthTech Companies, an honor that instantly ramps up its visibility and validates its push to make point-of-care ultrasound more accessible. On top of that, Butterfly Network has appointed Victor Ku as Senior Vice President and CTO, bringing deep engineering and leadership experience to the table,...

If you have been watching Citigroup (NYSE:C) lately, you know it has not been a quiet year for this banking giant. The stock’s eye-catching rally has grabbed the market’s attention, and the buzz is centered squarely around management’s recent moves and a wave of structural changes. Thanks to a renewed focus on institutional services and a leadership team that appears determined to rewrite Citi’s story, the company has shifted the conversation from past struggles to potential new heights...

Earlier in September 2025, Mastercard introduced a suite of AI-powered payment solutions, including Agent Pay for digital merchants, and expanded tools for developers through partnerships with Stripe, Google, and Antom. This move positions Mastercard at the forefront of secure, intelligent payments, reflecting its ambition to set new industry standards for agentic commerce worldwide. We'll examine how Mastercard's new AI-driven payment platforms and partnerships could influence its...

Earlier this month, investor commentary highlighted Inter & Co's position as Brazil's second-largest neo-bank and its expanding presence in Latin America and the United States, with a business model built on low-cost lending. This expansion is viewed by market watchers as a way for Inter & Co to tap into new, sizable markets and support longer-term earnings potential through geographic diversification. We'll examine how Inter & Co's growth ambitions in the U.S. could influence the company's...

Recently, the European Medicines Agency's Committee for Medicinal Products for Human Use recommended approval of Amgen’s Uplizna for treating immunoglobulin G4-related disease (IgG4-RD) in adults, based on strong Phase 3 data indicating significant efficacy where no authorized therapies currently exist in the EU. This milestone highlights the potential impact of Amgen’s pipeline in addressing rare autoimmune disorders with unmet medical needs in major markets. We'll examine how European...

We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...